✦ LIBER ✦

Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study

✍ Scribed by Ursula Schmidt-Erfurth; Bora Eldem; Robyn Guymer; Jean-François Korobelnik; Reinier O. Schlingemann; Ruth Axer-Siegel; Peter Wiedemann; Christian Simader; Margarita Gekkieva; Andreas Weichselberger

Book ID: 116805974
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 985 KB
Volume: 118
Category: Article
ISSN: 0161-6420
DOI: 10.1016/j.ophtha.2010.09.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patient preference of ranibizumab treatm

Patient preference of ranibizumab treatment regimen for neovascular age-related macular degeneration — monthly injections versus pro re nata

✍ Katharina M. Droege, Albert Caramoy… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 105 KB

Safety and Efficacy of a Flexible Dosing

Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study

✍ Frank G. Holz; Winfried Amoaku; Juan Donate; Robyn H. Guymer; Ulrich Kellner; Re 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 687 KB

Safety and Efficacy of Conbercept in Neo

Safety and Efficacy of Conbercept in Neovascular Age-Related Macular Degeneration

✍ Li, Xiaoxin; Xu, Gezhi; Wang, Yusheng; Xu, Xun; Liu, Xiaoling; Tang, Shibo; Zhan 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 795 KB

Subgroup Analysis of the MARINA Study of

Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration

✍ David S. Boyer; Andrew N. Antoszyk; Carl C. Awh; Robert B. Bhisitkul; Howard Sha 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 815 KB

Evaluation of the siRNA PF-04523655 vers

Evaluation of the siRNA PF-04523655 versus Ranibizumab for the Treatment of Neovascular Age-related Macular Degeneration (MONET Study)

✍ Nguyen, Quan Dong; Schachar, Ronald A.; Nduaka, Chudy I.; Sperling, Marvin; Klam 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 601 KB

Ranibizumab: A Review of Its Use in the

Ranibizumab: A Review of Its Use in the Treatment of Neovascular Age-Related Macular Degeneration

✍ James E. Frampton 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 752 KB